Ghent University Academic Bibliography

The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Ian W Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Arpad Illes, Gabriel Etienne, Julio Delgado, Bryone J Kuss, Constantine S Tam, Zoltan Gasztonyi, et al.

(2018) BLOOD. 132(23). p.2446-2455

Add to list

Journal Article
A1
open access

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia : extended phase 3 results from RESONATE-2

Paul M Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Osnat Bairey, Nancy L Bartlett, Jan A Burger, Peter Hillmen, Steven Coutre, Stephen Devereux, et al.

(2018) HAEMATOLOGICA. 103(9). p.1502-1510

Add to list

Journal Article
A1
open access

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotic, et al.

(2018) LEUKEMIA. 32(8). p.1768-1777

Add to list

Journal Article
A1
open access

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, Fritz Offner, D Caballero, C Joao, M Witzens-Harig, G Hess, et al.

(2018) LEUKEMIA. 32(8). p.1799-1803

Add to list

Journal Article
A1
open access

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment : a multicenter randomized controlled trial

Helene M Schoemans, Kathy Goris, Raf Van Durm, Steffen Fieuws, Sabina De Geest, Steven Z Pavletic, Annie Im, Daniel Wolff, Stephanie J Lee, Hildegard Greinix, et al.

(2018) HAEMATOLOGICA. 103(10). p.1698-1707

Add to list

Journal Article
A1
open access

The long non-coding RNA landscape in juvenile myelomonocytic leukemia

Mattias Hofmans (UGent) , Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Silvia Bresolin, Hélène Cavé, Christian Flotho, Henrik Hasle, Marry M van den Heuvel-Eibrink, Charlotte Niemeyer, Jan Stary, et al.

(2018) HAEMATOLOGICA. 103(11). p.e501-e504

Add to list

Performance of the preanalytical check module of the Stago STA R Max2 mechanical endpoint detection analyzer for assessing the impact of hemolysis, lipemia, and icterus on aPTT and PT

Lisa Florin (UGent) , Matthijs Oyaert (UGent) , Tom Van Maerken (UGent) and Katrien Devreese (UGent)

(2018) INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 40(6). p.e109-e112

Add to list

Mediastinal myeloid sarcoma with TP53 mutation preceding acute myeloid leukemia with a PICALM-MLLT10 fusion gene

Leslie Naesens (UGent) , Helena Devos, Friedel Nollet, Lucienne Michaux and Dominik Selleslag

(2018) ACTA HAEMATOLOGICA. 140(2). p.97-104

Add to list

Journal Article
A1
open access

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Renate De Smedt (UGent) , Sofie Peirs (UGent) , Julie Morscio (UGent) , Filip Matthijssens (UGent) , Juliette Roels (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , Steven Goossens (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , et al.

(2018) HAEMATOLOGICA. 104(1). p.e17-e20

Add to list

Recurrently affected genes in juvenile myelomonocytic leukaemia

Julia C Obenauer, Francois G Kavelaars, Mathijs A Sanders, Andrica CH de Vries, Valerie de Haas, H Berna Beverloo, Barbara De Moerloose (UGent) , Tim Lammens (UGent) , Michael Dworzak, Remco M Hoogenboezem, et al.

(2018) BRITISH JOURNAL OF HAEMATOLOGY. 182(1). p.135-138

Academic Bibliography

The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia : extended phase 3 results from RESONATE-2

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment : a multicenter randomized controlled trial

The long non-coding RNA landscape in juvenile myelomonocytic leukemia

Performance of the preanalytical check module of the Stago STA R Max2 mechanical endpoint detection analyzer for assessing the impact of hemolysis, lipemia, and icterus on aPTT and PT

Mediastinal myeloid sarcoma with TP53 mutation preceding acute myeloid leukemia with a PICALM-MLLT10 fusion gene

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

Recurrently affected genes in juvenile myelomonocytic leukaemia

Contents

Support

Contact